Nanostring to webcast panel on ai-based genomics and drug discovery from the 43rd annual cowen health care conference

Seattle--(business wire)--nanostring technologies, inc. (nasdaq:nstg), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to participate in a panel discussion, “ai-driven disruptions to genomics & computational drug discovery”, from the 43rd annual cowen health care conference. the conference will be held march 6-8, 2023.
NSTG Ratings Summary
NSTG Quant Ranking